- Split Biosciences, a Seattle, WA-based company providing researchers scalable and flexible single cell sequencing solutions, raised $7M in Series A funding
- The round led by Bioeconomy Capital with participation from new and existing angel investors
- The company also intends to use the funds to continue scaling the commercial roll-out of its Whole Transcriptome Kit
- Parse Biosciences is a company which is advancing Whole Transcriptome Kit, which enables researchers to profile up to 100,000 cells in parallel across up to 48 samples
- In addition to increased scalability, the technology also provides researchers with higher data quality and enables them to increase gene detection in individual cells
- The Whole Transcriptome Kit already used in 40 labs across the country, providing these researchers with improved resolution and throughput in their experiments
